CYTOKINETICS INC — Director's Dealing 2013

Jan 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2013-01-02

Reporting Person: DOW STEPHEN M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-02	Stock Option (Right To Buy)	$.6702	A	130588	Acquired	2023-01-02	Common Stock (130588)	Direct

Footnotes

F1: Options shall vest and become exercisable in equal monthly installments such that the options shall be 100% vested on January 2, 2014.

F2: This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of annual retainer of $35,000.